Cases & Deals

Idenix establishes patent portfolio related to nucleoside analog antiviral drugs

Clients Idenix Pharmaceuticals, Inc.

Jones Day represents Idenix Pharmaceuticals, Inc. in the management and development of a patent portfolio related to nucleoside analog antiviral drugs.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.